New combo drug may cut painkiller use in ventilated newborns

NCT ID NCT07241351

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding dexmedetomidine (a sedative) to fentanyl (a painkiller) could reduce the amount of fentanyl needed for full-term newborns on breathing machines. Forty babies were given either a lower fentanyl dose plus dexmedetomidine or standard fentanyl alone. Researchers tracked pain scores and how many extra painkiller doses were needed, while watching for side effects like slow heart rate or low blood pressure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexmedetomidine (a sedative) and fentanyl (a painkiller)
What this could lead to
If it works, this could help reduce the amount of fentanyl needed for newborns on breathing machines, potentially lowering side effects.
What could go wrong
This is a small, early-phase study with only 40 babies. It may not show clear benefits, and risks like slow heart rate or low blood pressure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain Shams University Hospitals

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.